|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.5100 - 1.5900|
|52 Week Range||0.5100 - 1.6500|
|Beta (3Y Monthly)||2.05|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2018 - Nov 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LOS ANGELES, CA / ACCESSWIRE / February 1, 2019 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted as of February 1, 2019. Again. We have always held the belief that our industry ...
Stereotaxis (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias announced today a partnership with Kansas City Heart Rhythm Institute to bring new and cutting-edge treatments to arrhythmia patients. Kansas City Heart Rhythm Institute (KCHRI), a part of HCA Midwest Health, the region’s largest healthcare provider, will establish a new program which will be based at Overland Park Regional Medical Center to expand access to advanced robotic technology for the treatment of cardiac arrhythmias.
Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 11th Annual LD Micro Main Event investor conference. Mr. Fischel will provide an overview of the Company's technology and business strategy during his presentation on Tuesday, December 4, 2018 at 7:30 a.m. PT. In addition, he will be available to participate in one-on-one meetings with investors and other conference attendees, which can be scheduled by registering for the event at www.ldmicro.com/events. The conference will be held at the Luxe Sunset Bel Air Hotel and will feature approximately 250 companies in the small-cap/micro-cap space.
NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Stereotaxis, Inc. (NASDAQ: STXS ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 10:00 AM Eastern Time. To ...
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Stereotaxis Inc. ( OTCQX: STXS ) and OurPet's Co. ( OTCQX: OPCO ), ...